The cranial sensors used in Affinity testing were a proprietary design, and their specifications had not been among the data Meir Klein had provided. We determined that the closest equivalent was a neural scanning sensor manufactured by a company in Guangzhou called AllMedTest. These were dime-sized devices, incredibly sophisticated, and an array of six or seven would be enough to generate the kind of imaging the test required. But they were expensive, and buying them in quantity would be a major investment. When I approached Damian about it, he said not to worry: “We have T-Bourse money to invest, and I can’t think of a better use for it.” “Okay, but the sensors are fairly delicate, which we have to factor into the design. And my tech guys have to know exactly how much processing power they need to build into a portable device. They’re complaining that the flow of information from the theoretical side has slowed way down.” “They’re right,” Damian said. “The thing is, we’ve come across some anomalies in Klein’s data.”
